Volpara Health has acquired CRA Health, a spinout of Havard Medical School’s teaching hospital Massachusetts General Hospital.

CRA Health, a US-based breast cancer risk assessment technology spinout of Havard University teaching hospital Massachusetts General Hospital, has been acquired by healthcare software developer Volpara Health.
Volpara is paying $18m to purchase all outstanding equity of CRA, with another $4m dependent on milestones.
CRA has built a cloud-based platform that integrates with electronic health record (EHR) systems, collating patient information such as breast density to determine the risk of breast cancer and make treatment recommendations.
Ralph Highnam, group CEO of Volpara, said: “The acquisition of CRA is very significant for Volpara. CRA is a leading provider of risk assessment tools within major EHR systems and has integrations already established with the main genetics companies.
“CRA brings world-class knowledge about risk and genetics. CRA will accelerate us on our mission to save families from cancer by preventing advanced stage breast cancer.”

Thierry Heles

Thierry Heles is the former editor-at-large of Global University Venturing and Global Corporate Venturing, and was the producer and host of the Beyond the Breakthrough podcast until December 2024.